Authors: de Jong, MC Slootstra, JW Scheffer, GL Schroeijers, AB Puijk, WC Dinkelberg, R Kool, M Broxterman, HJ Meloen, RH Scheper, RJ

Citation: Mc. De Jong et al., Peptide transport by the multidrug resistance protein MRP1, CANCER RES, 61(6), 2001, pp. 2552-2557

Authors: Schroeijers, AB Siva, AC Scheffer, GL de Jong, MC Bolick, SCE Dukers, DF Slootstra, JW Meloen, RH Wiemer, E Kickhoefer, VA Rome, LH Scheper, RJ

Citation: Ab. Schroeijers et al., The M-r 193,000 vault protein is up-regulated in multidrug-resistant cancer cell lines, CANCER RES, 60(4), 2000, pp. 1104-1110

Authors: Scheffer, GL Kool, M Heijn, M de Haas, M Pijnenborg, ACLM Wijnholds, J van Helvoort, A de Jong, MC Hooijberg, JH Mol, CAAM van der Linden, M de Vree, JML van der Valk, P Elferink, RPJO Borst, P Scheper, RJ

Citation: Gl. Scheffer et al., Specific detection of multidrug resistance proteins MRP1, MRP2, MRP3, MRP5, and MDR3 P-glycoprotein with a panel of monoclonal antibodies, CANCER RES, 60(18), 2000, pp. 5269-5277

Authors: Scheffer, GL Maliepaard, M Pijnenborg, ACLM van Gastelen, MA de Jong, MC Schroeijers, AB van der Kolk, DM Allen, JD Ross, DD van der Valk, P Dalton, WS Schellens, JHM Scheper, RJ

Citation: Gl. Scheffer et al., Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone- and topotecan-resistant cell lines, CANCER RES, 60(10), 2000, pp. 2589-2593

Authors: Hooijberg, JH Broxterman, HJ Scheffer, GL Vrasdonk, C Heijn, M de Jong, MC Scheper, RJ Lankelma, J Pinedo, HM

Citation: Jh. Hooijberg et al., Potent interaction of flavopiridol with MRP1, BR J CANC, 81(2), 1999, pp. 269-276

Authors: Izquierdo, MA Scheffer, GL Schroeijers, AB de Jong, MC Scheper, RJ

Citation: Ma. Izquierdo et al., Vault-related resistance to anticancer drugs determined by the expression of the major vault protein LRP, CYTOTECHNOL, 27(1-3), 1998, pp. 137-148